Increasing levels of poor sleep and sleep disorders affects at least one in five Australians, leading to an estimated $66 billion a year in lost productivity […]
Confirmation of 40 new genetic markers takes forward the development of the first tests to assess a person’s risk of developing glaucoma, a leading cause of […]
Flinders is at the forefront of finding solutions for glaucoma, the leading cause of irreversible blindness worldwide. By 2020, glaucoma will affect 80 million people worldwide, […]
From diabetes, cancer and heart disease to chronic pain and major depression, 12 new research grants announced today cap off a big year for Flinders medical […]
Ophthalmology experts at Flinders have played a pivotal role in discovering a new genetic cause for primary congenital glaucoma – a leading cause of blindness in children.
The discovery of new genetic areas linked to an increased risk of glaucoma will help prevent one of the leading cause of irreversible blindness in Asia.
Research into eating, eye, sleep and autoimmune disorders were among the nine outstanding papers awarded the Flinders University Best Research Higher Degree Student publications for 2015.
Dementia, bowel cancer and glaucoma are among diseases to be addressed by researchers at Flinders with National Health and Medical Research Council funding of nearly $5.1 million.
A person’s chance of developing glaucoma – the leading cause of blindness worldwide – could now be easier to predict following the discovery of new disease-related genes by Flinders researchers.